Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Luliconazole Cream 1% PK in Pediatric Tinea Pedis/Cruris
NCT02767271Phase 4Completed
- Sponsor
- Valeant Pharmaceuticals
- Start
- Dec 2015
- Primary completion
- Apr 2016
- Countries
- 2
01
Overview
Phase 4, open-label trial of luliconazole vehicle cream in tinea pedis and Tinea cruris (TC) (2 arms), sponsored by Valeant Pharmaceuticals. Primary endpoints: Maximum Observed Plasma Concentration at Day 8, Area Under the Plasma Concentration Versus Time Curve From Time 0 to 24 Hours and 1 more. Started Dec 2015; status: completed.
02
Drugs
luliconazole vehicle cream
03
Conditions
tinea pedisTinea cruris (TC)
Beyond the preview
Go deeper on NCT02767271.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02767271.